月別アーカイブ: 2014年4月

ReCept Pharmacy's Proactive Approach to Financial and Co-Pay Assistance Delivers for Patients!

FORT WORTH, Texas, April 29, 2014 /PRNewswire/ — ReCept Pharmacy, LP, announced today that, to date, they have assisted over 3,000 under-insured patients in obtaining in excess of $2.5 million in financial and co-pay assistance.

ReCept Pharmacy's Helping Hands Logo symbolizes the organization's dedication to “making people feel better”.

“Our specialty pharmacy teams understand the importance of diligently working with co-pay and charitable foundation assistance programs to secure access to medications that often have a high patient financial responsibility,” explains Carmine DeNardo, CEO of ReCept Pharmacy.

ReCept Pharmacy arranged $1.2 million in assistance for 2013.  As part of an ongoing commitment for continued patient outreach, ReCept is projected to help patients obtain over $5 million of financial and co-pay assistance in 2014.

“Financial barriers are one of the most common hurdles preventing patients from starting or continuing on their specialty therapy,” says Vaughn Kinosian, Vice President of Operations.  “ReCept takes a proactive approach to addressing these hurdles to help get patients started on their medication and ultimately keep them adherent to therapy”.

Additionally, ReCept’s clinically-trained and knowledgeable pharmacists provide patients with proactive services to help them stay compliant and persistent on their specialty medication. Such services include  specific disease state education, side-effect management, refill reminder programs and convenient delivery of their medication.  “It’s all part of ReCept’s comprehensive, high-touch model and overall mission to ‘make people feel better’ while promoting improved health,” adds Carmine.

About ReCept Pharmacy

As a leader in the Specialty Pharmacy industry in the Southwest, ReCept cares for patients throughout a regional network of pharmacies located in Texas. With over 35 years of experience in providing pharmacy care, ReCept employs a knowledgeable, dedicated clinical staff to manage patients with complex chronic conditions. ReCept specializes in serving patients and their treating physicians within the therapeutic classes of Autoimmune, Hepatitis, HIV, Oncology, Compounding and Pain Management. Taking a holistic approach to patient management, ReCept understands specific disease states, their treatments and the effects those treatments have on individual patients. An avid commitment to keep patients adherent and compliant with their treatment regimen is ongoing. The ReCept corporate mission is simple: “To make people feel better” and improve their overall quality of life. For additional information on ReCept Pharmacy, please visit: www.receptrx.com

Logo - http://photos.prnewswire.com/prnh/20140429/82049

Source Article from http://ca.finance.yahoo.com/news/recept-pharmacys-proactive-approach-financial-212000399.html
ReCept Pharmacy's Proactive Approach to Financial and Co-Pay Assistance Delivers for Patients!
http://ca.finance.yahoo.com/news/recept-pharmacys-proactive-approach-financial-212000399.html
http://news.search.yahoo.com/news/rss?p=pharmacy
pharmacy – Yahoo News Search Results
pharmacy – Yahoo News Search Results





ReCept Pharmacy's Proactive Approach to Financial and Co-Pay Assistance Delivers for Patients!

FORT WORTH, Texas, April 29, 2014 /PRNewswire/ — ReCept Pharmacy, LP, announced today that, to date, they have assisted over 3,000 under-insured patients in obtaining in excess of $2.5 million in financial and co-pay assistance.

ReCept Pharmacy's Helping Hands Logo symbolizes the organization's dedication to “making people feel better”.

“Our specialty pharmacy teams understand the importance of diligently working with co-pay and charitable foundation assistance programs to secure access to medications that often have a high patient financial responsibility,” explains Carmine DeNardo, CEO of ReCept Pharmacy.

ReCept Pharmacy arranged $1.2 million in assistance for 2013.  As part of an ongoing commitment for continued patient outreach, ReCept is projected to help patients obtain over $5 million of financial and co-pay assistance in 2014.

“Financial barriers are one of the most common hurdles preventing patients from starting or continuing on their specialty therapy,” says Vaughn Kinosian, Vice President of Operations.  “ReCept takes a proactive approach to addressing these hurdles to help get patients started on their medication and ultimately keep them adherent to therapy”.

Additionally, ReCept’s clinically-trained and knowledgeable pharmacists provide patients with proactive services to help them stay compliant and persistent on their specialty medication. Such services include  specific disease state education, side-effect management, refill reminder programs and convenient delivery of their medication.  “It’s all part of ReCept’s comprehensive, high-touch model and overall mission to ‘make people feel better’ while promoting improved health,” adds Carmine.

About ReCept Pharmacy

As a leader in the Specialty Pharmacy industry in the Southwest, ReCept cares for patients throughout a regional network of pharmacies located in Texas. With over 35 years of experience in providing pharmacy care, ReCept employs a knowledgeable, dedicated clinical staff to manage patients with complex chronic conditions. ReCept specializes in serving patients and their treating physicians within the therapeutic classes of Autoimmune, Hepatitis, HIV, Oncology, Compounding and Pain Management. Taking a holistic approach to patient management, ReCept understands specific disease states, their treatments and the effects those treatments have on individual patients. An avid commitment to keep patients adherent and compliant with their treatment regimen is ongoing. The ReCept corporate mission is simple: “To make people feel better” and improve their overall quality of life. For additional information on ReCept Pharmacy, please visit: www.receptrx.com

Logo - http://photos.prnewswire.com/prnh/20140429/82049

Source Article from http://ca.finance.yahoo.com/news/recept-pharmacys-proactive-approach-financial-212000399.html
ReCept Pharmacy's Proactive Approach to Financial and Co-Pay Assistance Delivers for Patients!
http://ca.finance.yahoo.com/news/recept-pharmacys-proactive-approach-financial-212000399.html
http://news.search.yahoo.com/news/rss?p=pharmacy
pharmacy – Yahoo News Search Results
pharmacy – Yahoo News Search Results





BioAlliance Pharma Publishes Its First Shareholder Newsletter

PARIS–(BUSINESS WIRE)–

Regulatory News:

BioAlliance Pharma SA (Euronext Paris – BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announces the publication of its first Shareholder Newsletter (1).

This Newsletter completes BioAlliance Pharma’s communication with all of its shareholders, in addition to its website, its press releases and its participation in the financial community events.

This first issue follows the press release of April 16, 2014, announcing the planned merger between BioAlliance Pharma and Topotarget to create a leading orphan oncology company. Judith Greciet, CEO of BioAlliance Pharma, addresses shareholders to present this merger’s key points: its expected benefits, major assets to drive growth and value, key transaction details and its consequences.

(1) The Shareholder Newsletter is available on the website at: www.bioalliancepharma.com (News or Investors).

About BioAlliance Pharma

Dedicated to cancer treatments with a focus on resistance targeting and orphan products, BioAlliance Pharma conceives and develops innovative products for orphan or rare diseases.

Created in 1997 and introduced to the Euronext Paris market in 2005, BioAlliance Pharma’s ambition is to become a leading player in these fields by coupling innovation to patient needs. The company’s teams have the key competencies required to identify, develop and register drugs in Europe and the USA.

BioAlliance Pharma has developed an advanced product portfolio:

Orphan Oncology products
Livatag® (Doxorubicin Transdrug™) (primary liver cancer): Phase III on going
Validive® (Clonidine Lauriad®) (mucositis): Phase II on going
AMEP® (invasive melanoma): Phase I on going

For more information, visit the BioAlliance Pharma web site at www.bioalliancepharma.com

Disclaimer

This communication expressly or implicitly contains certain forward-looking statements concerning BioAlliance Pharma SA and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of BioAlliance Pharma SA to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. BioAlliance Pharma SA is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of BioAlliance Pharma SA to differ from those contained in the forward-looking statements, please refer to the Risk Factors (“Facteurs de Risque”) section of the 2013 Reference Document filed with the AMF on April 7, 2014, which is available on the AMF website (http://www.amf-france.org) or on BioAlliance Pharma SA’s website (www.bioalliancepharma.com).

Source Article from http://finance.yahoo.com/news/bioalliance-pharma-publishes-first-shareholder-190000785.html
BioAlliance Pharma Publishes Its First Shareholder Newsletter
http://finance.yahoo.com/news/bioalliance-pharma-publishes-first-shareholder-190000785.html
http://news.search.yahoo.com/news/rss?p=pharma
pharma – Yahoo News Search Results
pharma – Yahoo News Search Results